ISRCTN15873887进行中(未招募)3 期
A randomized, parallel-group, comparative investigation of M045A in the treatment of recurrent aphthous stomatitis
Mucocort AB0 个研究点目标入组 50 人开始时间: 2024年8月14日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Males or females, 12 -70 years of age
- •2. =2 RAS episodes over the past 6 months
- •3. =3 wounds at the time of the study visit
- •4. The diameter of the wounds <10 mm
- •5. The pain from RAS =4 on the NRS
- •6. The subjects should have the ability and willingness to provide informed consent
排除标准
- •1. Treated at any time with mucosal topical, oral, or systemic corticosteroids less than 1 month prior to screening.
- •2. On TNF-alpha modulating drugs or DMARDs less than 1 month prior to screening
- •3. Suffering from any oral mucosal disease other than RAS at the time of enrollment
- •4. Any other condition as judged by the investigator to make the investigation inappropriate
- •5. Current alcohol or substance abuse
- •6. Participating in any other clinical trial or have participated in any other clinical trial within 1 month prior to the study start
研究者
相似试验
已完成
3 期
A Clinical Study to determine the efficacy and safety of Inj Diclofenac 75mg/mL given as an IV injection versus Diclofenac 75mg/3mL given as an IV infusion in the management of postoperative paiCTRI/2010/091/000096Troikaa Pharmaceuticals Limited250
尚未招募
3 期
A study where vomiting after cesarean operation is compared among 3 groups who receive spinal anesthesia by 3 different drugsCTRI/2024/03/064486Office of the Principal
已完成
3 期
Evaluation of local application of Myostaal liniment in strengthening muscles in knee arthritisCTRI/2020/11/029031Solumiks Herbaceuticals Limited70
已完成
2 期
Add on efficacy and safety of Myostaal liniment for the reduction of spasticity of the muscles with only Physiotherapy given group.CTRI/2020/12/029850Solumiks Herbaceuticals Limited33
已完成
4 期
A non-blind, randomized, parallel group comparative trial to study the efficacy and safety of Mao-to in the treatment of influenza.Influenza Type A and Type BJPRN-UMIN000001653Fukuoka University Hospital30
